- IBDEI2WE ; ; 04-FEB-2020
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,46225,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,46225,1,3,0)
- ;;=3^Keratoconus,Right Eye
- ;;^UTILITY(U,$J,358.3,46225,1,4,0)
- ;;=4^H18.601
- ;;^UTILITY(U,$J,358.3,46225,2)
- ;;=^5005089
- ;;^UTILITY(U,$J,358.3,46226,0)
- ;;=H18.602^^176^2302^16
- ;;^UTILITY(U,$J,358.3,46226,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,46226,1,3,0)
- ;;=3^Keratoconus,Left Eye
- ;;^UTILITY(U,$J,358.3,46226,1,4,0)
- ;;=4^H18.602
- ;;^UTILITY(U,$J,358.3,46226,2)
- ;;=^5005090
- ;;^UTILITY(U,$J,358.3,46227,0)
- ;;=H18.423^^176^2302^17
- ;;^UTILITY(U,$J,358.3,46227,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,46227,1,3,0)
- ;;=3^Band Keratopathy,Bilateral
- ;;^UTILITY(U,$J,358.3,46227,1,4,0)
- ;;=4^H18.423
- ;;^UTILITY(U,$J,358.3,46227,2)
- ;;=^5005068
- ;;^UTILITY(U,$J,358.3,46228,0)
- ;;=H16.213^^176^2302^18
- ;;^UTILITY(U,$J,358.3,46228,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,46228,1,3,0)
- ;;=3^Exposure Keratoconjunctivitis,Bilateral
- ;;^UTILITY(U,$J,358.3,46228,1,4,0)
- ;;=4^H16.213
- ;;^UTILITY(U,$J,358.3,46228,2)
- ;;=^5004922
- ;;^UTILITY(U,$J,358.3,46229,0)
- ;;=H18.833^^176^2302^19
- ;;^UTILITY(U,$J,358.3,46229,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,46229,1,3,0)
- ;;=3^Recurrent Erosion of Cornea,Bilateral
- ;;^UTILITY(U,$J,358.3,46229,1,4,0)
- ;;=4^H18.833
- ;;^UTILITY(U,$J,358.3,46229,2)
- ;;=^5005128
- ;;^UTILITY(U,$J,358.3,46230,0)
- ;;=B00.51^^176^2302^20
- ;;^UTILITY(U,$J,358.3,46230,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,46230,1,3,0)
- ;;=3^Herpesviral Iridocyclitis
- ;;^UTILITY(U,$J,358.3,46230,1,4,0)
- ;;=4^B00.51
- ;;^UTILITY(U,$J,358.3,46230,2)
- ;;=^5000473
- ;;^UTILITY(U,$J,358.3,46231,0)
- ;;=B00.52^^176^2302^21
- ;;^UTILITY(U,$J,358.3,46231,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,46231,1,3,0)
- ;;=3^Herpesviral Keratitis
- ;;^UTILITY(U,$J,358.3,46231,1,4,0)
- ;;=4^B00.52
- ;;^UTILITY(U,$J,358.3,46231,2)
- ;;=^5000474
- ;;^UTILITY(U,$J,358.3,46232,0)
- ;;=B00.59^^176^2302^22
- ;;^UTILITY(U,$J,358.3,46232,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,46232,1,3,0)
- ;;=3^Herpes Viral Eye Disease
- ;;^UTILITY(U,$J,358.3,46232,1,4,0)
- ;;=4^B00.59
- ;;^UTILITY(U,$J,358.3,46232,2)
- ;;=^5000476
- ;;^UTILITY(U,$J,358.3,46233,0)
- ;;=B02.39^^176^2302^23
- ;;^UTILITY(U,$J,358.3,46233,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,46233,1,3,0)
- ;;=3^Herpes Zoster Eye Disease
- ;;^UTILITY(U,$J,358.3,46233,1,4,0)
- ;;=4^B02.39
- ;;^UTILITY(U,$J,358.3,46233,2)
- ;;=^5000498
- ;;^UTILITY(U,$J,358.3,46234,0)
- ;;=H16.309^^176^2302^24
- ;;^UTILITY(U,$J,358.3,46234,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,46234,1,3,0)
- ;;=3^Interstitial Keratitis,Unspec Eye
- ;;^UTILITY(U,$J,358.3,46234,1,4,0)
- ;;=4^H16.309
- ;;^UTILITY(U,$J,358.3,46234,2)
- ;;=^5133472
- ;;^UTILITY(U,$J,358.3,46235,0)
- ;;=S05.01XA^^176^2302^25
- ;;^UTILITY(U,$J,358.3,46235,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,46235,1,3,0)
- ;;=3^Corneal Abrasion w/o FB,Right Eye,Init Enctr
- ;;^UTILITY(U,$J,358.3,46235,1,4,0)
- ;;=4^S05.01XA
- ;;^UTILITY(U,$J,358.3,46235,2)
- ;;=^5020579
- ;;^UTILITY(U,$J,358.3,46236,0)
- ;;=S05.02XA^^176^2302^26
- ;;^UTILITY(U,$J,358.3,46236,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,46236,1,3,0)
- ;;=3^Corneal Abrasion w/o FB,Left Eye,Init Enctr
- ;;^UTILITY(U,$J,358.3,46236,1,4,0)
- ;;=4^S05.02XA
- ;;^UTILITY(U,$J,358.3,46236,2)
- ;;=^5020582
- ;;^UTILITY(U,$J,358.3,46237,0)
- ;;=T15.01XA^^176^2302^27
- ;;^UTILITY(U,$J,358.3,46237,1,0)
- ;;=^358.31IA^4^2
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2WE 3749 printed Feb 19, 2025@00:03:34 Page 2
- IBDEI2WE ; ; 04-FEB-2020
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,46225,1,0)
- +2 ;;=^358.31IA^4^2
- +3 ;;^UTILITY(U,$J,358.3,46225,1,3,0)
- +4 ;;=3^Keratoconus,Right Eye
- +5 ;;^UTILITY(U,$J,358.3,46225,1,4,0)
- +6 ;;=4^H18.601
- +7 ;;^UTILITY(U,$J,358.3,46225,2)
- +8 ;;=^5005089
- +9 ;;^UTILITY(U,$J,358.3,46226,0)
- +10 ;;=H18.602^^176^2302^16
- +11 ;;^UTILITY(U,$J,358.3,46226,1,0)
- +12 ;;=^358.31IA^4^2
- +13 ;;^UTILITY(U,$J,358.3,46226,1,3,0)
- +14 ;;=3^Keratoconus,Left Eye
- +15 ;;^UTILITY(U,$J,358.3,46226,1,4,0)
- +16 ;;=4^H18.602
- +17 ;;^UTILITY(U,$J,358.3,46226,2)
- +18 ;;=^5005090
- +19 ;;^UTILITY(U,$J,358.3,46227,0)
- +20 ;;=H18.423^^176^2302^17
- +21 ;;^UTILITY(U,$J,358.3,46227,1,0)
- +22 ;;=^358.31IA^4^2
- +23 ;;^UTILITY(U,$J,358.3,46227,1,3,0)
- +24 ;;=3^Band Keratopathy,Bilateral
- +25 ;;^UTILITY(U,$J,358.3,46227,1,4,0)
- +26 ;;=4^H18.423
- +27 ;;^UTILITY(U,$J,358.3,46227,2)
- +28 ;;=^5005068
- +29 ;;^UTILITY(U,$J,358.3,46228,0)
- +30 ;;=H16.213^^176^2302^18
- +31 ;;^UTILITY(U,$J,358.3,46228,1,0)
- +32 ;;=^358.31IA^4^2
- +33 ;;^UTILITY(U,$J,358.3,46228,1,3,0)
- +34 ;;=3^Exposure Keratoconjunctivitis,Bilateral
- +35 ;;^UTILITY(U,$J,358.3,46228,1,4,0)
- +36 ;;=4^H16.213
- +37 ;;^UTILITY(U,$J,358.3,46228,2)
- +38 ;;=^5004922
- +39 ;;^UTILITY(U,$J,358.3,46229,0)
- +40 ;;=H18.833^^176^2302^19
- +41 ;;^UTILITY(U,$J,358.3,46229,1,0)
- +42 ;;=^358.31IA^4^2
- +43 ;;^UTILITY(U,$J,358.3,46229,1,3,0)
- +44 ;;=3^Recurrent Erosion of Cornea,Bilateral
- +45 ;;^UTILITY(U,$J,358.3,46229,1,4,0)
- +46 ;;=4^H18.833
- +47 ;;^UTILITY(U,$J,358.3,46229,2)
- +48 ;;=^5005128
- +49 ;;^UTILITY(U,$J,358.3,46230,0)
- +50 ;;=B00.51^^176^2302^20
- +51 ;;^UTILITY(U,$J,358.3,46230,1,0)
- +52 ;;=^358.31IA^4^2
- +53 ;;^UTILITY(U,$J,358.3,46230,1,3,0)
- +54 ;;=3^Herpesviral Iridocyclitis
- +55 ;;^UTILITY(U,$J,358.3,46230,1,4,0)
- +56 ;;=4^B00.51
- +57 ;;^UTILITY(U,$J,358.3,46230,2)
- +58 ;;=^5000473
- +59 ;;^UTILITY(U,$J,358.3,46231,0)
- +60 ;;=B00.52^^176^2302^21
- +61 ;;^UTILITY(U,$J,358.3,46231,1,0)
- +62 ;;=^358.31IA^4^2
- +63 ;;^UTILITY(U,$J,358.3,46231,1,3,0)
- +64 ;;=3^Herpesviral Keratitis
- +65 ;;^UTILITY(U,$J,358.3,46231,1,4,0)
- +66 ;;=4^B00.52
- +67 ;;^UTILITY(U,$J,358.3,46231,2)
- +68 ;;=^5000474
- +69 ;;^UTILITY(U,$J,358.3,46232,0)
- +70 ;;=B00.59^^176^2302^22
- +71 ;;^UTILITY(U,$J,358.3,46232,1,0)
- +72 ;;=^358.31IA^4^2
- +73 ;;^UTILITY(U,$J,358.3,46232,1,3,0)
- +74 ;;=3^Herpes Viral Eye Disease
- +75 ;;^UTILITY(U,$J,358.3,46232,1,4,0)
- +76 ;;=4^B00.59
- +77 ;;^UTILITY(U,$J,358.3,46232,2)
- +78 ;;=^5000476
- +79 ;;^UTILITY(U,$J,358.3,46233,0)
- +80 ;;=B02.39^^176^2302^23
- +81 ;;^UTILITY(U,$J,358.3,46233,1,0)
- +82 ;;=^358.31IA^4^2
- +83 ;;^UTILITY(U,$J,358.3,46233,1,3,0)
- +84 ;;=3^Herpes Zoster Eye Disease
- +85 ;;^UTILITY(U,$J,358.3,46233,1,4,0)
- +86 ;;=4^B02.39
- +87 ;;^UTILITY(U,$J,358.3,46233,2)
- +88 ;;=^5000498
- +89 ;;^UTILITY(U,$J,358.3,46234,0)
- +90 ;;=H16.309^^176^2302^24
- +91 ;;^UTILITY(U,$J,358.3,46234,1,0)
- +92 ;;=^358.31IA^4^2
- +93 ;;^UTILITY(U,$J,358.3,46234,1,3,0)
- +94 ;;=3^Interstitial Keratitis,Unspec Eye
- +95 ;;^UTILITY(U,$J,358.3,46234,1,4,0)
- +96 ;;=4^H16.309
- +97 ;;^UTILITY(U,$J,358.3,46234,2)
- +98 ;;=^5133472
- +99 ;;^UTILITY(U,$J,358.3,46235,0)
- +100 ;;=S05.01XA^^176^2302^25
- +101 ;;^UTILITY(U,$J,358.3,46235,1,0)
- +102 ;;=^358.31IA^4^2
- +103 ;;^UTILITY(U,$J,358.3,46235,1,3,0)
- +104 ;;=3^Corneal Abrasion w/o FB,Right Eye,Init Enctr
- +105 ;;^UTILITY(U,$J,358.3,46235,1,4,0)
- +106 ;;=4^S05.01XA
- +107 ;;^UTILITY(U,$J,358.3,46235,2)
- +108 ;;=^5020579
- +109 ;;^UTILITY(U,$J,358.3,46236,0)
- +110 ;;=S05.02XA^^176^2302^26
- +111 ;;^UTILITY(U,$J,358.3,46236,1,0)
- +112 ;;=^358.31IA^4^2
- +113 ;;^UTILITY(U,$J,358.3,46236,1,3,0)
- +114 ;;=3^Corneal Abrasion w/o FB,Left Eye,Init Enctr
- +115 ;;^UTILITY(U,$J,358.3,46236,1,4,0)
- +116 ;;=4^S05.02XA
- +117 ;;^UTILITY(U,$J,358.3,46236,2)
- +118 ;;=^5020582
- +119 ;;^UTILITY(U,$J,358.3,46237,0)
- +120 ;;=T15.01XA^^176^2302^27
- +121 ;;^UTILITY(U,$J,358.3,46237,1,0)
- +122 ;;=^358.31IA^4^2